Our client is a prestigious Contract Development Manufacturing Organisation (CDMO) based in the UK and specialising in new formulations.
They were working with a new novel highly potent compound, which they were aiming to compress into tablet form. They approached ONFAB with a request to contain their existing Manesty F3 tablet press to OEB4 level so that the work could be conducted safely.
In order to maintain product consistency and a valid batch profile, it was important to the client to keep their existing SOP and ergonomics where possible; the operator needed to retain their ability to control and adjust the press power and tablet dies.
Download the full case study to discover how our solution helped the client contain their process to OEB 4 level, and hit a challenging deadline.